Edenight

Edenight is a clinical-stage biotechnology company focused on developing innovative therapies for sleep disorders and central nervous system conditions. The company's lead programs utilize small molecule approaches to modulate key neurotransmitter systems involved in the regulation of sleep-wake cycles. Edenight aims to address significant unmet needs in the treatment of insomnia by providing therapies with improved safety profiles and efficacy compared to existing standards of care. Their research emphasizes the development of compounds that promote natural sleep architecture without the common side effects associated with traditional sedatives.